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Zusammenfassung 
Neuropsychologische Störungen äußern sich in unterschiedlichen Symptomen, 
die oft zu deutlichen funktionellen Einschränkungen des Alltagslebens führen. 
Forschung, Diagnostik und Behandlung sollten diesen Alltagsbezug unter 
Berücksichtigung von Symptomen, Persönlichkeit und Lebensumständen der 
betroffenen Patienten einbeziehen. Messungen mit Methoden des Ambulanten 
Assessment bieten dabei einen Fortschritt durch Vermeidung von retrospek-
tiven Erinnerungsverzerrungen, durch erhöhte ökologische Validität und durch 
die Generierung individueller Zeitreihen, die idiographische Analysen ermögli-
chen. Am Beispiel der Multiplen Sklerose stellen wir in den Bereichen Erschöpf-
ung, Stress und kognitive Funktionen dar, welche neuartigen Erkenntnisse mit 
Methoden des ambulanten Assessment in der Vergangenheit gewonnen wurden, 
und wir zeigen zukünftige diagnostische Möglichkeiten auf, die diese Methode in 
der Forschung und klinischen Praxis mit Multiple-Sklerose-Patienten bietet. 
 
Schlüsselwörter: Multiple Sklerose; Ambulantes Assessment; Ecological 
Momentary Assessment; Erschöpfung; Stress; Cortisol; kognitive Funktionen 
 
 
 
 
Abstract 
Neuropsychological disorders involve a variety of symptoms that often lead to 
substantial functional impairments in daily life. Research, assessment, and treat-
ment should include a reference to daily life, considering symptoms, personality, 
and life circumstances of the individual patient. Ambulatory assessment metho-
dology provides progress by avoiding retrospective memory-based bias, increa-
sing ecological validity, and by generating individual time series that permit idio-
graphic analysis. Using multiple sclerosis as an example, we illustrate new find-
ings generated by ambulatory assessment studies in the areas of fatigue, stress 
and cognitive functions, and we demonstrate future opportunities presented by 
ambulatory assessment methodology to research and clinical practice with 
multiple sclerosis patients. 
 
Keywords: Multiple sclerosis; ambulatory assessment; ecological momentary 
assessment; fatigue; stress; cortisol; cognitive functions 
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Introduction 
Neuropsychological assessment usually happens in 
clinical settings. This applies to the assessment of 
cognitive functioning, psychological stress, depressive 
symptoms, fatigue, pain, and negative affect, often 
assessed as important patient reported outcomes 
(PROs) in clinical research. Although clinical 
assessment settings benefit from a relatively high 
degree of control over the assessment process, it is 
important to note that they nevertheless have several 
shortcomings, such as reliance on retrospective self-
reports, an artificial setting outside of the patient’s 
daily life, and information collected at a single point in 
time that lacks detail on within-subject dynamics and 
relationships or processes that evolve over time. In 
recent years, methods of assessment in daily life have 
grown in popularity. Although these assessment 
methodologies come under different labels and were 
developed on the basis of different methodological 
origins (Wilhelm, Perrez, & Pawlik, 2012), they share 
common characteristics. The most widely-used types 
are Ambulatory Assessment (Ebner-Priemer & Kubiak, 
2010; Fahrenberg & Myrtek, 1996; Trull & Ebner-
Priemer, 2013), Ecological Momentary Assessment 
(Shiffman, Stone, & Hufford, 2008; Stone & Shiffman, 
1994), and Experience Sampling Methodology 
(Csikszentmihalyi & Larson, 1992). Daily life research 
is characterised by its focus on real life (Reis, 2012), 
real time (Schwarz, 2012), and repeated assessments 
within subjects (Hamaker, 2012), and often explicitly 
incorporates data from assessment methods targeting 
different domains, i.e. physiological, subjective-
emotional, behavioural, and cognitive (Mehl & Conner, 
2012). In the following, we use the term ambulatory 
assessment to refer to the variety of daily life 
assessment methodologies. In clinical neuropsycholo-
gy, daily life assessment methodologies generally 
present opportunities for a broader approach to clinical 
diagnosis which is likely to yield more valid results as 
well as interventions with much increased relevance 
for patients’ everyday lives. Incorporating daily life 
assessment methodologies could be beneficial for a 
wide variety of questions in neuropsychological 
research, diagnostics, and especially for treatment. To 
illustrate this point, we will discuss a selection of three 
topics that are of high relevance for neuropsychological 
assessment, i.e. fatigue, psychological stress and 
cognitive function. Using multiple sclerosis (MS) as an 
example, we will illustrate how daily life assessment 
methods might provide highly relevant complementary 
information to conventional assessment methods. 
Multiple sclerosis-related impairments in daily life 
MS is a chronic inflammatory demyelinating disease of 
the central nervous system that presents itself as 
relapsing-remitting MS (RRMS) with recurrent 
episodes of symptom exacerbations and full or partial 
symptom recovery, secondary progressive MS with 
gradual clinical progression independent of exacer-
bations, or primary progressive MS with gradual 
clinical progression without exacerbations (Miller & 
Leary, 2007; Noseworthy, Lucchinetti, Rodriguez, & 
Weinshenker, 2000; Rovaris et al., 2006).  
The lesions or plaques that result from damage to 
the myelin sheath lead to symptoms in a variety of 
organ systems such as tremor, loss of vision, poor 
balance, stiffness and painful spasms, bladder dysfunc-
tion, cognitive impairment, depression, and fatigue 
(Chiaravalloti & DeLuca, 2008; Compston & Coles, 
2008; Krupp, Serafin, & Christodoulou, 2010; Siegert & 
Abernethy, 2005; Ziemssen, 2009). Due to the variety 
of organ systems that are affected and the severity of 
symptoms, MS leads to substantial functional impair-
ments in daily life. Besides the severe impact on people 
with MS and members of their social network, the 
disease's high costs also have an indirect effect on the 
wider society. It has been estimated that MS was 
associated with costs of approximately € 14.6 billion in 
Europe in the year 2010 (Olesen, Gustavsson, Svensson, 
Wittchen, & Jonsson, 2012).  
While the aetiology of MS is largely unknown, both 
genetic and environmental factors seem to be major 
causal factors (Compston & Coles, 2008). Although a 
number of pharmacological interventions for MS can 
reduce disease activity (disease modifying therapies), 
therapies that achieve full recovery or complete cure of 
the disease do not exist and are among the major aims 
of development of future treatments (Compston & 
Coles, 2008; Noseworthy, et al., 2000). Consequently, 
non-pharmacological interventions that might help to 
alleviate symptoms, moderate disease activity, or 
reduce the impact of symptoms on the everyday lives of 
MS patients would be of great importance for MS 
treatment. In this context it is interesting to note that 
recent evidence suggests that psychological stress 
might play a role in symptom exacerbation and relapse 
(Artemiadis, Anagnostouli, & Alexopoulos, 2011; Mohr, 
Hart, Julian, Cox, & Pelletier, 2004). 
Due to the prognostic uncertainty typical of MS, 
patients need to be well informed about their illness 
(Noseworthy, et al., 2000). Broad and reliable infor-
mation about MS symptoms helps patients to 
effectively self-manage their condition in daily life, 
which is often necessary due to the unpredictability 
and severity of symptom appearance. In addition, 
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health care professionals involved in MS treatment and 
management, i.e. physicians, clinical neuropsycholo-
gists, and expert nurses should use all information on 
patients’ functional impairment and relevant internal 
and external resources available to the patient in daily 
life (such as coping skills or social support available to 
the patient) to improve the quality of life of MS patients. 
Subjective symptoms 
The subjective representation of symptoms is often 
reflected in patients’ complaints and are typically 
assessed by psychometric scales measuring the 
perception of specific or broader symptoms. Fatigue is 
a frequently reported symptom in different clinical 
groups, particularly MS patients. We will therefore use 
MS-related fatigue as an example to discuss some of the 
issues related to ambulatory assessment of subjective 
complaints in general. Although much of the 
methodological knowledge generated by such research 
can be generalized to the assessment of other 
complaints, it is important to keep in mind that details 
of the assessment design need to be tailored to the 
specific phenomenon of interest. For example, 
decisions on the frequency of assessments, expec-
tations on compliance rates achievable with the 
patients in the study, assessment devices and response 
scales to be used, and aggregate indicators to be 
derived from raw data can be very different for 
ambulatory assessments of fatigue, mood, balance, or 
other subjective complaints. 
 Unfortunately, there has so far been little focus 
on developing and utilizing ambulatory assessment 
techniques for fatigue measurement, not only in MS but 
in clinical populations in general. Typically, single-item 
measures have been utilised to measure momentary 
fatigue in those few clinical studies conducted, 
including modifications of the Brief Fatigue Inventory 
(BFI; Mendoza et al., 1999), the Rochester Fatigue Diary 
(Schwid, Covington, Segal, & Goodman, 2002), and 
other visual analogue scale (VAS) format items. Our 
research group, for example, has recently carried out a 
study in MS (Powell, Moss-Morris, Liossi, & Schlotz, in 
preparation) using a variation of the BFI to reflect both 
physical and mental fatigue in MS: “How much fatigue 
(tiredness, weariness, problems thinking clearly) do 
you feel right now?” with response by VAS ranging from 
0 (“No Fatigue”) to 10 (“Extreme Fatigue”). 
MS-related fatigue 
In a large epidemiological study, 74% of 9077 MS 
patients obtained scores indicative of severe fatigue 
(Hadjimichael, Vollmer, & Oleen-Burkey, 2008) on the 
Fatigue Severity Scale (Krupp, LaRocca, Muir-Nash, & 
Steinberg, 1989). High prevalence of fatigue in MS (60 
– 85%) has also been reported in other large-scale (n > 
500) studies (Lerdal, Celius, & Moum, 2003; Minden et 
al., 2006). However, the aetiology of MS-related fatigue 
is uncertain, and primary disease-related mechanisms 
as well as secondary mechanisms have been proposed 
(for reviews, see Induruwa, Constantinescu, & Gran, 
2012; Kos, Kerckhofs, Nagels, D'hooghe, & Ilsbroukx, 
2008; Krupp, et al., 2010). MS-related fatigue is most-
frequently defined as “a subjective lack of physical 
and/or mental energy that is perceived by the 
individual or caregiver to interfere with usual and 
desired activities” (Multiple Sclerosis Council for 
Clinical Practice Guidelines, 1998, p.2); however, 
multiple definitions exist (e.g., Comi, Leocani, Rossi, & 
Colombo, 2001; Mills & Young, 2008). Measuring 
fatigue is equally complex, and multiple self-report 
tools – of varying psychometric quality – are available 
to quantify subjective fatigue retrospectively in chronic 
illness (Whitehead, 2009). 
Ambulatory assessment of MS-related fatigue 
Retrospective recall necessarily requires the 
aggregation of phenomena over a period of time. 
However, MS patients typically describe fatigue as a 
fluctuating rather than stable and consistent pheno-
menon. Fatigue is typically described as being most 
severe in the late afternoon and sensitive to contextual 
effects of everyday experiences, such as psychological 
stress, physical and mental activity, heat and humidity, 
and poor sleep quality (Freal, Kraft, & Coryell, 1984; 
Mills & Young, 2008). This implies that the summary 
measures typically employed in research and clinical 
practice provide an incomplete representation of 
overall symptom experience, and lack important 
information about within-subject and within-day 
variability. Ambulatory assessment provides oppor-
tunity to prospectively examine fluctuations in fatigue 
severity in daily life, including diurnal fatigue patterns 
(fatigue changes with time) and quantifying the effects 
of contextual factors.  
 Despite its potential, only two studies have 
been published that utilise ambulatory assessment for 
the examination of MS-related fatigue in everyday life 
(Kim et al., 2010; Schwid et al., 2003), with the earlier 
study measuring fatigue within a randomised con-
trolled trial of cooling treatment for MS symptoms 
(Schwid, et al., 2003). Momentary fatigue assessments 
have also been used elsewhere in clinic-based settings 
in MS populations (Claros-Salinas et al., 2010; Feys et 
al., 2012; Morris, Cantwell, Vowels, & Dodd, 2002), but 
lack the fundamental advantage of ecological validity. 
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Kim et al. (2010) used Actiwatch wrist devices to 
prompt and measure fatigue severity at 9am, 1pm, 5pm, 
and 9pm over 21 consecutive days in 49 MS patients. 
Momentary fatigue was measured using a single-item 
numerical rating scale (Real-Time Digital Fatigue Score) 
ranging from “Energetic, No Fatigue” (score = 0) to 
“Worst Possible Fatigue” (score = 10). Using multilevel 
(mixed-effects) modelling, incremental increases in 
fatigue were reported over the course of the day, 
indicating a relatively linear diurnal fatigue pattern and 
providing prospective evidence supporting previous 
assertions (based on qualitative interviews and simple 
surveys) that fatigue is worst later in the day.  
Ambulatory assessment studies carried out in other 
clinical populations have tested hypotheses that are 
equally relevant in MS. For example, fatigue was 
associated with less concurrent and future physical 
activity but was not associated with prior physical 
activity in lagged-effects analyses in chronic fatigue 
syndrome and fibromyalgia (Kop et al., 2005). Testing 
whether similar temporal relationships exist in MS 
could potentially illuminate the use of all-or-nothing 
behaviours thought to contribute to perpetuating 
chronic fatigue in MS (Skerrett & Moss-Morris, 2006). 
Further, given the current reliance on recall measures, 
research and clinical practice may benefit from 
investigating the accuracy of and presence of bias 
within MS-related fatigue recall by using concurrent 
ambulatory assessment, as has been reported in other 
populations (e.g., Schneider, Stone, Schwartz, & 
Broderick, 2011).  
Compliance 
The level of compliance with measurement protocols in 
everyday life is a significant limitation to the study by 
Kim et al. (2010) and a challenge for ambulatory 
assessment research in general. Kim et al. (2010) 
reported that only 64% of wristwatch beeps elicited a 
response, which is possibly due to patients missing 
more events while fatigued or while having a heavier 
workload. Although multilevel modelling is robust to 
missed assessments (Graham, 2009), the 
representativeness of the sampling is threatened by 
relatively high levels of missing data. This highlights the 
importance of a careful examination of compliance 
when using ambulatory assessment methods. Gene-
rally speaking, compliance decreases with increasing 
effort, and this varies across patients. Therefore, the 
burden to patients needs to be kept at an acceptable 
individual level, while a sufficient number of assess-
ment needs to be carried out to be able to answer the 
questions of interest.  
Detailed targets for intervention 
There is very little understanding of which facets of 
fatigue experience are most important. It is well-
established that symptomatic fatigue has a negative 
impact on quality of life in MS (Amato et al., 2001; 
Janardhan & Bakshi, 2002); however, it is unclear 
whether it is characteristics such as symptom varia-
bility or periods of extreme symptom intensity that 
have the greatest impact on daily lives. Ambulatory 
assessment has the potential to contribute answers. A 
recent study presented several parameters that could 
be obtained from ambulatory assessment data of PROs: 
daily symptom means, variability (standard deviation), 
peaks (90th percentile), periods of no symptom 
experience (rating score = 0), and contingent-based 
(morning versus evening, work versus home) (Stone, 
Broderick, Schneider, & Schwartz, 2012). If, for 
example, the findings showed that periods of extreme 
fatigue intensity had the greatest impact on daily lives, 
therapies and treatments should target the lowering of 
90th percentile ratings in ambulatory assessment 
protocols. Summary recall measures do not provide 
within-subject repeated measures needed for such 
detailed outcome assessments and, in addition, may not 
be sufficiently sensitive to determine an effective 
treatment.  
Combining subjective and physiological assessments 
Ambulatory assessment traditionally utilises physiolo-
gical measures alongside measures of behaviour 
and/or internal-state subjective experience (Ebner-
Priemer & Kubiak, 2010). This may include the 
monitoring of physical activity (Shammas et al., 2014; 
Yang & Hsu, 2010) and cardiac output (Pickering, 
Shimbo, & Haas, 2006), as well as collecting saliva 
samples for endocrine markers (Schlotz, 2012). The 
role of cortisol as a potential mediator of any 
association between psychological stress and fatigue in 
MS provides a potential avenue for future research 
incorporating ambulatory assessment. Although Sali-
vary cortisol studies appear to suggest attenuated daily 
cortisol variability in chronic fatigue syndrome (Powell, 
Liossi, Moss-Morris, & Schlotz, 2013), no association 
was found between salivary cortisol output and fatigue 
in MS in a previous study (Gold et al., 2011). 
In summary, investigating fluctuations in fatigue 
experience seems an important future field of research 
which can be examined in real-time using ambulatory 
assessment methods. The identification of contextual 
and physiological factors in daily life that exacerbate 
fatigue severity should further our understanding of 
fatigue aetiology and has the potential to inform future 
treatment developments.  
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Psychological stress 
The measurement of human life stress is complex 
(Monroe, 2008), particularly when constructs are being 
targeted that have little or no objective equivalent, such 
as perceived stress. However, subjective represent-
tation of potentially stressful situations, i.e. perceived 
stress, are relevant predictors of disease (Cohen, 
Janicki-Deverts, & Miller, 2007) and provide important 
information complementary to life event records. 
Perceived stress in neuropsychological patients can be 
measured by several widely-used scales such as the 
Perceived Stress Scale (PSS; Cohen, Kamarck, & 
Mermelstein, 1983; Cohen & Williamson, 1988), 
Perceived Stress Questionnaire (PSQ; Fliege et al., 2005; 
Levenstein et al., 1993), or the Trier Inventory for 
Chronic Stress (TICS; Petrowski, Paul, Albani, & Brahler, 
2012; Schulz, Schlotz, & Becker, 2004). While attempts 
have been made to develop short scales that measure 
only the major factors (e.g. Lehman, Burns, Gagen, & 
Mohr, 2012; Schulz, et al., 2004), such short scales 
neglect important domain-specific information (e.g. 
Morgan, Umberson, & Hertzog, 2014). Although these 
scales have sufficient reliability and validity as 
indicated by psychometric analyses, they suffer from 
potential memory-related bias since the reports are 
being assessed retrospectively. Ambulatory assess-
ment methodology provides a relatively easy to ad-
minister and useful method to assess perceived stress 
with minimal or no memory-related bias during the 
patient’s daily routine. 
Although less relevant to clinical work, stress 
responses can be measured in a controlled environ-
ment using highly standardised stress procedures such 
as the Trier Social Stress Test (TSST) and related 
methods (Allen, Kennedy, Cryan, Dinan, & Clarke, 2014; 
Dickerson & Kemeny, 2004; Kirschbaum, Pirke, & 
Hellhammer, 1993). While laboratory stressors pro-
vide a high level of control over exposure and response 
assessment, this necessarily represents a relatively 
artificial situation and therefore has limited ecological 
validity. Due to high costs and the relatively high level 
of complexity involved in implementing laboratory 
stress tests, they usually cannot be applied in 
assessments of patients during routine clinical work, 
despite being useful and important tools for research 
projects. In addition, the lack of normative data for 
stress responses in such situations means that 
interpretation of assessment results would be difficult 
and of little value to the clinician for single-case 
diagnostics. Again, ambulatory assessment might be a 
feasible alternative, as a variety of physiological 
responses such as cortisol stress responses can in 
principle be assessed contemporaneously to self-
reports of perceived stress in daily life (Jacobs et al., 
2007; Powell & Schlotz, 2012; Schlotz, 2012). 
Stress and multiple sclerosis 
The impact of psychological stress on MS has been 
implied for some time (Charcot, 1887) and meta-
analyses have suggested that stressful life events 
increase the risk of symptom exacerbation in relapsing 
remitting MS (Artemiadis, et al., 2011; Mohr, et al., 
2004). MS patients also attribute stress with the 
worsening of symptoms; for example, 78% of 2529 MS 
patients believed that a high level of stress worsens 
symptoms generally (Simmons, Ponsonby, van der Mei, 
& Sheridan, 2004) and 82% of 635 MS patients felt 
stress increases the severity of their fatigue (Mills & 
Young, 2008). In addition, it has been found that 
perceived stress and certain emotion-focused coping 
strategies such as avoidance in MS patients were 
associated with worse adjustment to the disease 
indicated by lower quality of life or more depressive 
symptoms (Dennison, Moss-Morris, & Chalder, 2009). 
Improving the understanding of stress and coping 
processes in MS patients therefore might have 
important implications for MS (self-) management. 
It has been suggested that interventions for 
avoiding stress should be investigated in more detail 
for their potential to attenuate the disease process 
(Apel, Klauer, & Zettl, 2006). A recent randomised trial 
of stress management in MS patients provided evidence 
for a reduction of new gadolinium-enhancing (Gd+) and 
T2 lesions in magnetic resonance imaging (MRI) scans 
during the intervention, although these effects did not 
remain stable after treatment was finished (Mohr et al., 
2012). An additional analysis of data from this study 
suggested that major negative stressful events, but not 
moderate negative stressful events and perceived 
stress, predicted Gd+ lesions on MRI scans carried out 
1-2 months later (Burns, Nawacki, Kwasny, Pelletier, & 
Mohr, 2014). It is therefore unclear which type of 
stressor is typically relevant for MS progression, and 
why stress management generates clear positive 
effects that are nevertheless time-limited. 
As mentioned above, research in psychoneuroendo-
crinology and psychoneuroimmunology has suggested 
that the dysregulations of the hypothalamus-pituitary-
adrenal (HPA) axis and its end-product cortisol might 
be relevant for MS disease processes due to its well-
known immune-suppressive effects (Heesen et al., 
2007). As the HPA axis is sensitive to daily life stress, 
stress reactivity may play a major role in mediating 
potential associations between stress and MS symp-
toms. However, little evidence exists for this proposed 
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mechanism. Although the cortisol awakening respon-
ses (CAR) in daily life was found to be increased and 
associated with worsening of disability status in RRMS, 
it was not related to perceived stress (Kern et al., 2013). 
This suggests that daily life stress might contribute 
little to dysregulations of the HPA axis in MS. In contrast, 
HPA axis dysregulations are related to MS disease 
processes, and it could be speculated that up-regulation 
of cortisol secretion might help to reduce MS-related 
disability and probably other symptoms. However, 
despite findings of stress-relapse associations and 
patient-reported relevance of stress for worsening of 
symptoms, there is little evidence for a role of the HPA 
axis in this association.  
Future research directions 
In the future, ambulatory assessment might be used 
more extensively to investigate associations between 
daily life stress, cortisol secretion, and MS symptoms. 
For example, it has been suggested that the time course 
of stress responses might be of crucial importance for 
explaining a potential mediating role of HPA axis stress 
responses in MS exacerbations (Mohr & Pelletier, 
2006). This stress resolution hypothesis suggests that 
the cortisol reduction after stress resolution facilitates 
the development of active inflammation. Since patients 
with RRMS often show moderate levels of ongoing 
inflammation not noticeable to the patient (Mohr & 
Pelletier, 2006; Ysrraelit, Gaitán, Lopez, & Correale, 
2008), a period of relatively low cortisol levels 
following a stress response would increase the risk for 
an exacerbation. Ambulatory assessment would be 
suitable to test this hypothesis, although relatively long 
observation periods would be needed. 
In summary, using ambulatory assessment metho-
dology to assess stressors, perceived stress, stress 
responses, and coping behaviour in daily life presents 
unique opportunities for the collection of ecologically 
valid, unbiased information from different stress 
response systems that are highly relevant to the MS 
disease processes and symptom (self-)management. 
Cognitive function 
Unfortunately, ambulatory assessment of cognitive 
functioning in daily life is far from being readily 
available for researchers and clinicians. Although a 
number of researchers are working on the develop-
ment of assessments of cognitive function in daily life 
using mobile devices, none of them have so far been 
used in neuropsychological patients. However, it is 
noteworthy that cognitive test paradigms have been 
successfully used in everyday life settings using mobile 
devices. For example, a reaction time test has been 
successfully applied using the Stroop paradigm on 
hand-held computer, with expected correlations 
between reactions times in daily life and established 
psychometric tests in smokers (Waters & Li, 2008); an 
implicit association test also showed expected effects in 
smokers’ daily  lives (Waters, Miller, & Li, 2010). Using 
mobile phones, performance on attention and working 
memory tests was shown to be impaired in a within-
subject comparison of alcohol versus no alcohol 
consumed before assessments in daily life (Tiplady, 
Oshinowo, Thomson, & Drummond, 2009). Recently, a 
study on daily working memory and affect assessments 
showed that within-subject fluctuations in positive 
affect predicted better performance in working 
memory tasks independent of negative affect (Brose, 
Lovden, & Schmiedek, 2014). Despite these encoura-
ging developments, it is clear that much more work is 
needed to further improve such tests until they reach a 
standard where they can be used in clinical assessment. 
For example, thorough psychometric analyses are 
needed to establish reliability and validity, usability for 
neuropsychological patients’ needs to be established, 
and norm values are needed for diagnostic decisions in 
clinical work. Obviously, cognitive assessment in daily 
life is confounded by unsystematic variance due to 
factors such as noise, distraction of attention, or 
sleepiness. In addition, it has to be ascertained that 
patients are not exposed to any hazards in association 
with using mobile assessment devices in daily life 
(traffic; barriers; etc.). It would be best to clearly inform 
users how long an assessment will take and to instruct 
them to find a secure and relatively quiet place before 
starting an assessment. Finally, technological barriers 
need to be overcome for such tests to be readily 
available on mobile devices such as smartphones and 
tablet computer, as some of the users might be clinical 
experts, but technological laymen. 
Ambulatory assessment of cognitive function in multiple 
sclerosis 
Cognitive impairment can be observed in up to 70% of 
MS patients and often significantly affects their daily 
life activities and quality of life (Chiaravalloti & DeLuca, 
2008). Although general intelligence and essential 
verbal skills appear to be only slightly affected, if 
affected at all, some specific cognitive functions, most 
notably information processing efficiency, executive 
functions, processing speed, and long-term memory, 
show significant impairment (Chiaravalloti & DeLuca, 
2008). Assessment of cognitive functioning in MS 
should therefore be targeted to specific functions that 
are most strongly affected. A recommended test battery 
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comprises tests of word fluency, visuospatial ability, 
verbal memory, visuospatial memory, processing 
speed, working memory, and executive function 
(Benedict et al., 2006). 
However, assessment of cognitive function using a 
test battery is not readily available, time consuming, 
and expensive, and it does not provide any information 
on within-subject variability or impact on daily life 
activities. Moreover, two frequent symptoms of MS, 
fatigue and depression might affect performance and 
therefore would ideally be assessed contemporaneous-
ly with cognitive functioning. In an attempt to make 
relevant cognitive tests more readily available, an 
internet-based assessment has been developed which 
showed a high level sensitivity and specificity (Younes 
et al., 2007). Cognitive tests in daily life using 
ambulatory assessment methodology and devices such 
as smartphones or tablet computer would be similarly 
available and, in addition, repeated assessments would 
provide information on within-subject variability and 
diurnal trends. Moreover, contemporaneous assess-
ments of fatigue and depressive symptoms might 
reveal associations of these symptoms with cognitive 
functioning in MS (Feinstein, 2006), and assessments of 
daily life activities such as household chores or work-
related activities might provide information about the 
impact of individual cognitive deficits on daily life 
activities. This information could be used to develop 
rehabilitative interventions targeted to the individual 
patient with the aim of minimizing the impact of MS 
symptoms on daily life. In addition, combining ambu-
latory cognitive tests with ambulatory assessment of 
perceived stress, fatigue, and salivary cortisol might 
reveal insights into mutual influences of these systems. 
Limitations and outlook 
Neuropsychological assessments and interventions 
involve a variety of strategies, depending on symptoms, 
personality, and life circumstances of the individual 
patient. Due to the persistent nature of many 
neuropsychological conditions, clinical neuropsycholo-
gists often aim at improving patients’ quality of life by 
supporting them to manage symptoms effectively. 
Neuropsychological research aims at providing empiri-
cal evidence for making well-informed and effective 
clinical decisions, developing and evaluating innovative 
and effective strategies for symptom management, and 
understanding underlying mechanisms to minimise the 
negative impact of functional impairment on the 
patient’s quality of life. For all of these targets, reliable 
and valid assessment of symptoms and potentially 
relevant contributing factors is necessary. We argued 
that ambulatory assessment methodology provides 
opportunities to improve neuropsychological assess-
ment due to less retrospective memory-related bias, 
increased ecological validity, and a series of assess-
ments within subjects that provide opportunities for 
idiographic analysis. With a special emphasis on MS-
related research, we discussed ambulatory assessment 
studies that demonstrated diurnal variability in fatigue 
and changes in cortisol output after awakening that 
might help to better understand symptoms and 
mechanisms. Similarly, other symptoms relevant for 
neuropsychology such as pain could be assessed using 
ambulatory methods. Although cognitive symptoms 
cannot yet be assessed effortlessly in daily life, future 
developments might provide reliable and valid 
ambulatory cognitive tests. However, it is clear that 
these early studies are just the beginning of more 
detailed investigations of how neuropsychological 
conditions in general, and MS in particular, affect daily 
life.  
Limitations of ambulatory assessment methodology in 
neuropsychology 
Besides the strengths of ambulatory assessment, there 
are a number of limitations of this methodology in 
neuropsychological research and interventions. 
In addition to the potential negative effect of 
reactivity due to the relatively high number of 
assessments that might be perceived as a disturbance 
of daily life activities, disease-specific factors could 
limit the usability of ambulatory assessment methods. 
For example, cognitive, visual, and motor impairments 
that are very pronounced in some MS patients might 
limit the patients’ ability to provide accurate and timely 
responses. However, we have recently completed a 
study in RRMS patients with low to moderate disability 
(scores on the self-administered Expanded Disability 
Status Scale, EDSS, between 0.0 and 6.0) all of whom 
were able to do the e-diary ratings as well as saliva 
sampling without major problems. An initial piloting 
with two RRMS patients using the think-aloud method 
showed that only slight changes to the standard setup 
of a handheld-based e-diary were necessary to adapt it 
to the needs of the patients. However, patients with 
greater disability due to progressive types of MS might 
not be able to carry out ambulatory assessment 
protocols. This could lead to an overrepresentation of 
results from RRMS patients, and raise questions about 
the generalizability of the results, at least in those areas 
where active interaction with a response device is 
necessary. Increased availability of automated assess-
ment (see Bhake, Leendertz, Linthorst, & Lightman, 
2013 for an example of automated cortisol sampling) 
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and improved assistance functions of recording devices 
would be necessary to avoid this imbalance in the 
future. 
Another potential limitation of ambulatory assess-
ment methodology is related to compliance with the 
sampling schedule. As repeated assessments in daily 
life can be quite disruptive, patients may tend to miss 
assessments, especially in situations in which they 
suffer from high levels of stress or symptom experience. 
However, while undisclosed low compliance certainly 
can be a problem with paper-pencil diaries (Stone, 
Shiffman, Schwartz, Broderick, & Hufford, 2002), com-
puter-based assessment provides a much higher level 
of compliance monitoring. 
Finally, it should be noted that assessment in daily 
life necessarily lacks the high degree of control that can 
be applied in clinical or laboratory settings. Due to the 
large number of potentially confounding factors, only 
the most relevant factors can be assessed in addition to 
the target assessment. For example, situational 
variables such as social interactions, being at work or 
at home, or the current activity should be recorded, 
either automatically or by self-report. In addition, a 
function to postpone assessments should be available 
for the patient to be able to focus their attention 
completely on the assessment. Nevertheless, unsyste-
matic influences uncontrollable in daily life will unavoi-
dably increase error variance. However, such error 
variance can be reduced by increasing the number of 
assessments, and the influence of situational variables, 
if recorded, can be considered when analysing the data. 
Future developments 
The need for minimally disruptive, maximally flexible, 
highly assisting and automated procedures makes clear 
that ambulatory assessment methodology should make 
use of the latest technical computing developments, 
such as smartphones equipped with large high-
resolution displays with built-in or wireless sensors 
that are tailored to the patient’s needs. In the future, 
such devices might include instant patient-therapist-
communication triggered by relevant signals from 
momentary assessments. The fact that smartphones 
are increasingly becoming the standard for mobile 
personal communication will further help to 
implement ambulatory assessments as a minimally 
disruptive tool providing information that is highly 
valuable for both clinical professionals and patients. As 
technological innovations are being picked up by 
younger people with higher enthusiasm, the relatively 
young age of patients at first onset of MS might further 
support the implementation of ambulatory assessment 
methodology in the neuropsychology of MS. 
Besides possible future developments in the 
ambulatory assessment of fatigue, stress, and cognitive 
functioning, there are a number of areas in which 
ambulatory assessment methods in neuropsychology 
could be developed with the aim of improving usability, 
clinical diagnostics and symptom management more 
generally. For example, more work is needed to 
establish PROs that reflect the most relevant symptom 
experience in patients. Repeated ambulatory assess-
ments present the opportunity to compare different 
summary measures of symptom experience such as the 
90th percentile, standard deviation, maximum, or 
number of assessments without symptoms (Stone, et 
al., 2012). Studies might reveal that different summary 
measures reflect symptom experience differently in 
individual patients, which might be useful information 
for symptom-management of individual patients. 
The development of ambulatory assessment of 
neurocognitive functions would be of particular impor-
tance to neuropsychology. Although a few attempts 
have been made, much more systematic research is 
needed to develop ready-to-use assessments with 
satisfactory psychometric characteristics. Measures of 
working memory, attention, and emotion regulation to 
assess executive dysfunctions in daily life might be 
particularly important and suitable. When developing 
such ambulatory psychometric tests it has to be kept in 
mind that, besides a special consideration of usability, 
the major psychometric concepts of reliability and 
validity need to be extended, as the factor time adds to 
items and persons as a third source of variance. First 
suggestions and examples for more complex psycho-
metric analyses based on generalizability theory have 
been given (Cranford et al., 2006; Wilhelm & Schoebi, 
2007), but standards for psychometric indices or 
statistical parameters are lacking and need to be 
developed in future work. 
Future developments should also aim at reducing 
the burden of ambulatory assessment methods on 
patients by further improving usability and reducing 
measurement reactivity of ambulatory assessments. 
Although this is difficult to achieve, computerised 
adaptive testing (CAT) might be a useful perspective 
here, as the number of items needed for precise 
assessments can be reduced when a calibrated item 
pool is available (Rose et al., 2012).  
Finally, repeated assessments within subjects 
provide opportunities to investigate individual pro-
cesses from an idiographic perspective and detect 
Granger causality in clinical research projects (see 
Rosmalen, Wenting, Roest, de Jonge, & Bos, 2012, for an 
example). For example, mutual relationships between 
fatigue, depressive symptoms, and cognitive 
Schlotz & Powell: Ambulatory assessment in MS  10 
 
functioning in MS would be of interest to define 
intervention targets more precisely. Similarly, ambula-
tory assessment methods provide data suitable for 
single case experimental designs that can reveal useful 
information for clinical practice (Smith, 2012). 
In summary, using ambulatory assessment metho-
dology in clinical neuropsychological assessment and 
treatment presents the opportunity to implement 
multimethod-assessments in the patient’s daily life, to 
focus on specific situations relevant to everyday life, to 
investigate context-effects, and to use interactive 
feedback for process-focused psychological intervene-
tion studies. If applied expertly, such assessments 
result in higher ecological validity, less biased self-
reports, and higher precision, reliability, and validity of 
process-focused assessments. Current hard- and 
software already makes it possible to use ambulatory 
assessment strategies in assessment and treatment of 
MS symptoms, and future technological developments 
will increase the availability and usability of 
ambulatory assessment devices and procedures even 
further. These new developments present an important 
opportunity for clinical neuropsychologists to improve 
the assessment of symptoms and relevant psycholo-
gical and social factors, study disease processes, 
support patients to self-manage their disease, evaluate 
pharmacological interventions in daily life using PROs, 
support rehabilitation programs, and develop and 
investigate innovative non-pharmacological intervene-
tions. If these developments in neuropsychology are 
being used responsibly and implemented thoroughly, 
they might eventually help to increase the quality of life 
of neuropsychological patients. 
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